491 related articles for article (PubMed ID: 11833426)
1. Desensitization of adrenomedullin and calcitonin gene-related peptide receptors in vascular smooth muscle cells--effects of receptor activity-modifying protein.
Qi YF; Xue L; Chai SB; Shi YR; Pang YZ; Tang CS
Sheng Li Xue Bao; 2001 Oct; 53(5):396-400. PubMed ID: 11833426
[TBL] [Abstract][Full Text] [Related]
2. Desensitisation of calcitonin gene-related peptide responsiveness but not adrenomedullin responsiveness in vascular smooth muscle cells.
Drake WM; Lowe SR; Mirtella A; Bartlett TJ; Clark AJ
J Endocrinol; 2000 Apr; 165(1):133-8. PubMed ID: 10750043
[TBL] [Abstract][Full Text] [Related]
3. Effects of adrenomedullin on cyclic AMP formation and on relaxation in iris sphincter smooth muscle.
Yousufzai SY; Ali N; Abdel-Latif AA
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3245-53. PubMed ID: 10586949
[TBL] [Abstract][Full Text] [Related]
4. Progesterone upregulates calcitonin gene-related peptide and adrenomedullin receptor components and cyclic adenosine 3'5'-monophosphate generation in Eker rat uterine smooth muscle cell line.
Thota C; Yallampalli C
Biol Reprod; 2005 Feb; 72(2):416-22. PubMed ID: 15469997
[TBL] [Abstract][Full Text] [Related]
5. Desensitization of CGRP and adrenomedullin receptors in SK-N-MC cells: implications for the RAMP hypothesis.
Drake WM; Ajayi A; Lowe SR; Mirtella A; Bartlett TJ; Clark AJ
Endocrinology; 1999 Jan; 140(1):533-7. PubMed ID: 9886866
[TBL] [Abstract][Full Text] [Related]
6. Alterations of adrenomedullin and its receptor system components in calcified vascular smooth muscle cells.
Pan CS; Qi YF; Wang SH; Zhao J; Bu DF; Li GZ; Tang CS
Regul Pept; 2004 Aug; 120(1-3):77-83. PubMed ID: 15177923
[TBL] [Abstract][Full Text] [Related]
7. Desensitization and re-sensitization of CGRP receptor function in human neuroblastoma SK-N-MC cells.
Pin SS; Xu C; Bahr BA
Eur J Pharmacol; 2007 Dec; 577(1-3):7-16. PubMed ID: 17825280
[TBL] [Abstract][Full Text] [Related]
8. Effects of adrenomedullin and calcitonin gene-related peptide on contractions of the rat aorta and porcine coronary artery.
Yoshimoto R; Mitsui-Saito M; Ozaki H; Karaki H
Br J Pharmacol; 1998 Apr; 123(8):1645-54. PubMed ID: 9605572
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic changes of adrenomedullin receptor components, RAMP2, and CRLR mRNA expression in cultured rat vascular smooth muscle cells.
Makino I; Honda K; Makino Y; Okano I; Kangawa K; Kamiya H; Shibata K; Kawarabayashi T
Biochem Biophys Res Commun; 2001 Nov; 288(3):515-20. PubMed ID: 11676473
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and kinetic characterization of adrenomedullin 1 and calcitonin gene-related peptide 1 receptor reporter cell lines.
Wunder F; Rebmann A; Geerts A; Kalthof B
Mol Pharmacol; 2008 Apr; 73(4):1235-43. PubMed ID: 18174292
[TBL] [Abstract][Full Text] [Related]
11. Functional calcitonin gene-related peptide type 1 and adrenomedullin receptors in human trigeminal ganglia, brain vessels, and cerebromicrovascular or astroglial cells in culture.
Moreno MJ; Cohen Z; Stanimirovic DB; Hamel E
J Cereb Blood Flow Metab; 1999 Nov; 19(11):1270-8. PubMed ID: 10566974
[TBL] [Abstract][Full Text] [Related]
12. Adrenomedullin enhances baroreceptor reflex response via cAMP/PKA signaling in nucleus tractus solitarii of rats.
Ho LK; Chen K; Ho IC; Shen YC; Yen DH; Li FC; Lin YC; Kuo WK; Lou YJ; Yen JC
Neuropharmacology; 2008 Oct; 55(5):729-36. PubMed ID: 18616957
[TBL] [Abstract][Full Text] [Related]
13. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.
Bühlmann N; Leuthäuser K; Muff R; Fischer JA; Born W
Endocrinology; 1999 Jun; 140(6):2883-90. PubMed ID: 10342881
[TBL] [Abstract][Full Text] [Related]
14. Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms.
Nikitenko LL; Blucher N; Fox SB; Bicknell R; Smith DM; Rees MC
J Cell Sci; 2006 Mar; 119(Pt 5):910-22. PubMed ID: 16495482
[TBL] [Abstract][Full Text] [Related]
15. Studies on the effects of the N-terminal domain antibodies of calcitonin receptor-like receptor and receptor activity-modifying protein 1 on calcitonin gene-related peptide-induced vasorelaxation in rat uterine artery.
Chauhan M; Gangula PR; Wimalawansa SJ; Yallampalli C
Biol Reprod; 2004 Jun; 70(6):1658-63. PubMed ID: 14960487
[TBL] [Abstract][Full Text] [Related]
16. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
17. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
[TBL] [Abstract][Full Text] [Related]
18. Antiapoptotic effect of calcitonin gene-related peptide on oxidative stress-induced injury in H9c2 cardiomyocytes via the RAMP1/CRLR complex.
Sueur S; Pesant M; Rochette L; Connat JL
J Mol Cell Cardiol; 2005 Dec; 39(6):955-63. PubMed ID: 16242145
[TBL] [Abstract][Full Text] [Related]
19. Identification of an orphan receptor gene as a type 1 calcitonin gene-related peptide receptor.
Kapas S; Clark AJ
Biochem Biophys Res Commun; 1995 Dec; 217(3):832-8. PubMed ID: 8554605
[TBL] [Abstract][Full Text] [Related]
20. Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist.
Hasbak P; Saetrum Opgaard O; Eskesen K; Schifter S; Arendrup H; Longmore J; Edvinsson L
J Pharmacol Exp Ther; 2003 Jan; 304(1):326-33. PubMed ID: 12490608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
